RecallGuardianCanada
Drugs· Updated February 19, 2024

APO-Mometasone nasal spray: Two lots recalled due to possible risk of infection

Critical priority
Recalled product: APO-Mometasone nasal spray: Two lots recalled due to possible risk of infection
What you should do
  1. 1Do not use the affected product.
  2. 2Return it to your local pharmacy for proper disposal.
  3. 3Seek medical attention if you or your child have used this product and are experiencing persistent or worsening symptoms, such as fevers, or facial pain or pressure.
  4. 4Consult a health care professional if you or your child have used this product and have health concerns.
  5. 5Contact Apotex Inc.
The issue

Contamination

Affected product

APO-Mometasone nasal spray, 50 mcg/metered spray

Where it was sold

Canada (national)Reported in the official notice — confirm there.

Issued by

Health Canada

Read the official Government of Canada notice

RecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.

All recalls